Pulmonary Embolism Devices Market
Market Outline: Pulmonary Embolism Devices Market
Pulmonary embolism is a blockage in one of the aspiratory courses in your lungs. Much of the time, pulmonary embolism is caused by blood clumps that movement to the lungs from the legs or, once in a while, different parts of the body (deep vein thrombosis).
Market Dynamics: Pulmonary Embolism Devices Market
The pulmonary embolism devices Market is growing at a significant CAGR due to increase in geriatric population. Rise in the government expenditure, increase in the incidence of pulmonary embolism devices, and high unmet needs of currently available treatment procedures are fuelling the pulmonary embolism devices Market. Growing patient awareness regarding pulmonary embolism expected to boost the pulmonary embolism devices Market over the forecast period. However, high cost of devices, difficult pathophysiology of the pulmonary embolism hinder the growth of pulmonary embolism devices Market. Similarly, stringent regulatory approvals for the development of products is hindering the growth of pulmonary embolism devices Market over the forecast period.
Market Scope: Pulmonary Embolism Devices Market
The Pulmonary Embolism Devices Market is classified on the basis of type, end userand geographical regions.
Based on the type, Pulmonary Embolism Devices Market is segmented into
- Neurovascular Embolectomy Devices
- Embolectomy Balloon Catheters
- Percutaneous Thrombectomy Devices
- Catheter-Directed Thrombolysis Devices
Based on End User, Pulmonary Embolism Devices Market is segmented into
- Diagnostic centres
- Ambulatory surgical centres
- Rest of Europe
- Australia & New Zealand
- ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
- South Korea
- Rest of Asia-Pacific
- Rest of Latin America
Middle East and Africa (MEA)
- Gulf Cooperation Council (GCC) Countries
- South Africa
- Rest of MEA
Market Summary: Pulmonary Embolism Devices Market
Globally, pulmonary embolism devices Market is expected to grow at expeditiously owing to increase in incidences of pulmonary embolism. Several local and international players are actively involved in the growth of pulmonary embolism devices Market. The growth of pulmonary embolism devices Market is increased due to rise in prevalence of venous thromboembolism (According to the International Society on Thrombosis and Haemostasis, Inc.(ISTH), approximately 10 Mn cases of venous thromboembolism occur annually). The most commonly adopted strategies by industry players include new product launches with technological innovations, new product approvals, acquisitions & mergers, agreements, and collaborations to capture significant pulmonary embolism devices Market share.
Regional Analysis: Pulmonary Embolism Devices Market
Geographically Pulmonary Embolism Devices Market is segmented as Latin America, North America, Asia- Pacific, The Middle East & Africa and Europe. North America anticipated to hold the largest share in the pulmonary embolism Devices Market owing to increase in the incidence (According to U.S. International Society on Thrombosis and Haemostasis, Inc. (ISTH) there are around 100,000 to 300,000 venous thromboembolism related deaths reported annually) and prevalence rate, rise in demand for advanced treatment, and increase in aging population in the North America region may hold the largest share. Moreover, high healthcare expenditure, high awareness regarding the disease and treatments, and increase in prevalence rate the Europe region holds a major share in pulmonary embolism Devices Market over the forecast period. Asia-Pacific is a key region for pulmonary embolism Devices Market due to increase in the government expenditure and healthcare infrastructure.
Market participants: Pulmonary Embolism Devices Market
Some of the players in Pulmonary Embolism Devices Market
- Fukuda Denshi Co., Ltd (Japan)
- Baxter International Inc. (U.S)
- Lidco Group Plc(U.K)
- All Pro Corporation (China)
- Abbott Laboratories (U.S)
- Accellent, Inc.(U.S)
- Cardiva Medical, Inc.(U.S)
- Biosensors International Group, Ltd.(Singapore)
- 3M Healthcare (U.S)